GO:0010388 | cullin deneddylation | 2.53e-04 | 1.00e+00 | 6.347 | 2 | 4 | 8 |
GO:0000775 | chromosome, centromeric region | 2.58e-04 | 1.00e+00 | 4.574 | 3 | 6 | 41 |
GO:0005654 | nucleoplasm | 9.15e-04 | 1.00e+00 | 1.742 | 9 | 68 | 876 |
GO:0008135 | translation factor activity, nucleic acid binding | 9.35e-04 | 1.00e+00 | 5.440 | 2 | 4 | 15 |
GO:0034080 | CENP-A containing nucleosome assembly | 1.68e-03 | 1.00e+00 | 5.025 | 2 | 2 | 20 |
GO:0004842 | ubiquitin-protein transferase activity | 2.06e-03 | 1.00e+00 | 2.863 | 4 | 17 | 179 |
GO:0008180 | COP9 signalosome | 2.41e-03 | 1.00e+00 | 4.762 | 2 | 6 | 24 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.55e-03 | 1.00e+00 | 2.360 | 5 | 17 | 317 |
GO:0004832 | valine-tRNA ligase activity | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 1 |
GO:0035312 | 5'-3' exodeoxyribonuclease activity | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 1 |
GO:0051908 | double-stranded DNA 5'-3' exodeoxyribonuclease activity | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 1 |
GO:0000939 | condensed chromosome inner kinetochore | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 1 |
GO:0048256 | flap endonuclease activity | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 1 |
GO:0006281 | DNA repair | 3.25e-03 | 1.00e+00 | 2.681 | 4 | 24 | 203 |
GO:0003743 | translation initiation factor activity | 5.68e-03 | 1.00e+00 | 4.137 | 2 | 8 | 37 |
GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity | 6.14e-03 | 1.00e+00 | 7.347 | 1 | 1 | 2 |
GO:0048742 | regulation of skeletal muscle fiber development | 6.14e-03 | 1.00e+00 | 7.347 | 1 | 1 | 2 |
GO:0051716 | cellular response to stimulus | 6.14e-03 | 1.00e+00 | 7.347 | 1 | 1 | 2 |
GO:0004647 | phosphoserine phosphatase activity | 6.14e-03 | 1.00e+00 | 7.347 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 6.14e-03 | 1.00e+00 | 7.347 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 6.14e-03 | 1.00e+00 | 7.347 | 1 | 1 | 2 |
GO:2000781 | positive regulation of double-strand break repair | 6.14e-03 | 1.00e+00 | 7.347 | 1 | 1 | 2 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 9.19e-03 | 1.00e+00 | 6.762 | 1 | 2 | 3 |
GO:0036123 | histone H3-K9 dimethylation | 9.19e-03 | 1.00e+00 | 6.762 | 1 | 1 | 3 |
GO:0000778 | condensed nuclear chromosome kinetochore | 9.19e-03 | 1.00e+00 | 6.762 | 1 | 2 | 3 |
GO:0006563 | L-serine metabolic process | 9.19e-03 | 1.00e+00 | 6.762 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 9.19e-03 | 1.00e+00 | 6.762 | 1 | 1 | 3 |
GO:0006334 | nucleosome assembly | 1.06e-02 | 1.00e+00 | 3.674 | 2 | 4 | 51 |
GO:0045292 | mRNA cis splicing, via spliceosome | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 4 |
GO:0097452 | GAIT complex | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 4 |
GO:0032057 | negative regulation of translational initiation in response to stress | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 4 |
GO:0006333 | chromatin assembly or disassembly | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 4 |
GO:0036124 | histone H3-K9 trimethylation | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 4 |
GO:0006564 | L-serine biosynthetic process | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 4 |
GO:0005851 | eukaryotic translation initiation factor 2B complex | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 4 |
GO:0071156 | regulation of cell cycle arrest | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 4 |
GO:0016779 | nucleotidyltransferase activity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 4 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 4 |
GO:0090344 | negative regulation of cell aging | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 5 |
GO:0035519 | protein K29-linked ubiquitination | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 5 |
GO:0006282 | regulation of DNA repair | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 5 |
GO:0060744 | mammary gland branching involved in thelarche | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 5 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 5 |
GO:0044314 | protein K27-linked ubiquitination | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 5 |
GO:0004523 | RNA-DNA hybrid ribonuclease activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 6 |
GO:0043566 | structure-specific DNA binding | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 6 |
GO:0085020 | protein K6-linked ubiquitination | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 6 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 6 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 6 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 6 |
GO:0046578 | regulation of Ras protein signal transduction | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 6 |
GO:0002199 | zona pellucida receptor complex | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 4 | 7 |
GO:0007140 | male meiosis | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 7 |
GO:0008409 | 5'-3' exonuclease activity | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 7 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 7 |
GO:0000339 | RNA cap binding | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 7 |
GO:0000780 | condensed nuclear chromosome, centromeric region | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 4 | 7 |
GO:0051382 | kinetochore assembly | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 7 |
GO:0001649 | osteoblast differentiation | 2.15e-02 | 1.00e+00 | 3.137 | 2 | 5 | 74 |
GO:0005845 | mRNA cap binding complex | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 8 |
GO:0035102 | PRC1 complex | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 8 |
GO:0030529 | ribonucleoprotein complex | 2.60e-02 | 1.00e+00 | 2.989 | 2 | 5 | 82 |
GO:0010225 | response to UV-C | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 2 | 9 |
GO:0006379 | mRNA cleavage | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 2 | 9 |
GO:0032039 | integrator complex | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 9 |
GO:0005736 | DNA-directed RNA polymerase I complex | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 10 |
GO:0008143 | poly(A) binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 10 |
GO:0009416 | response to light stimulus | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 4 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 4 | 11 |
GO:0008652 | cellular amino acid biosynthetic process | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 2 | 11 |
GO:0008334 | histone mRNA metabolic process | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 1 | 11 |
GO:0000132 | establishment of mitotic spindle orientation | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 12 |
GO:0004527 | exonuclease activity | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 4 | 12 |
GO:0006413 | translational initiation | 3.68e-02 | 1.00e+00 | 2.717 | 2 | 6 | 99 |
GO:0005515 | protein binding | 3.77e-02 | 1.00e+00 | 0.507 | 18 | 198 | 4124 |
GO:0045190 | isotype switching | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 1 | 13 |
GO:0060749 | mammary gland alveolus development | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 1 | 13 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 1 | 13 |
GO:0000738 | DNA catabolic process, exonucleolytic | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 1 | 13 |
GO:0003723 | RNA binding | 3.93e-02 | 1.00e+00 | 1.983 | 3 | 22 | 247 |
GO:0003682 | chromatin binding | 4.13e-02 | 1.00e+00 | 1.954 | 3 | 15 | 252 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 1 | 14 |
GO:0016575 | histone deacetylation | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 2 | 14 |
GO:0000188 | inactivation of MAPK activity | 4.51e-02 | 1.00e+00 | 4.440 | 1 | 1 | 15 |
GO:0014003 | oligodendrocyte development | 4.51e-02 | 1.00e+00 | 4.440 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 4.51e-02 | 1.00e+00 | 4.440 | 1 | 4 | 15 |
GO:0003887 | DNA-directed DNA polymerase activity | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 2 | 16 |
GO:0005739 | mitochondrion | 4.82e-02 | 1.00e+00 | 1.304 | 5 | 32 | 659 |
GO:0007049 | cell cycle | 4.83e-02 | 1.00e+00 | 2.501 | 2 | 8 | 115 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.92e-02 | 1.00e+00 | 1.514 | 4 | 29 | 456 |
GO:0001227 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 2 | 17 |
GO:0006513 | protein monoubiquitination | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 1 | 17 |
GO:0006298 | mismatch repair | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 1 | 17 |
GO:0031667 | response to nutrient levels | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 2 | 17 |
GO:0031047 | gene silencing by RNA | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 2 | 18 |
GO:0033574 | response to testosterone | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 1 | 18 |
GO:0031519 | PcG protein complex | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 3 | 18 |
GO:0000398 | mRNA splicing, via spliceosome | 5.84e-02 | 1.00e+00 | 2.347 | 2 | 15 | 128 |
GO:0006913 | nucleocytoplasmic transport | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 2 | 20 |
GO:0070979 | protein K11-linked ubiquitination | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 3 | 20 |
GO:0046966 | thyroid hormone receptor binding | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 3 | 20 |
GO:0071346 | cellular response to interferon-gamma | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 2 | 20 |
GO:0051321 | meiotic cell cycle | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 1 | 20 |
GO:0005720 | nuclear heterochromatin | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 3 | 20 |
GO:0071897 | DNA biosynthetic process | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 2 | 20 |
GO:0034660 | ncRNA metabolic process | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 1 | 20 |
GO:0006363 | termination of RNA polymerase I transcription | 6.26e-02 | 1.00e+00 | 3.954 | 1 | 3 | 21 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 6.26e-02 | 1.00e+00 | 3.954 | 1 | 2 | 21 |
GO:0006139 | nucleobase-containing compound metabolic process | 6.55e-02 | 1.00e+00 | 3.887 | 1 | 2 | 22 |
GO:0030331 | estrogen receptor binding | 6.55e-02 | 1.00e+00 | 3.887 | 1 | 2 | 22 |
GO:0051084 | 'de novo' posttranslational protein folding | 6.55e-02 | 1.00e+00 | 3.887 | 1 | 4 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 6.55e-02 | 1.00e+00 | 3.887 | 1 | 1 | 22 |
GO:0000278 | mitotic cell cycle | 7.06e-02 | 1.00e+00 | 1.637 | 3 | 28 | 314 |
GO:0044212 | transcription regulatory region DNA binding | 7.10e-02 | 1.00e+00 | 2.187 | 2 | 13 | 143 |
GO:0006370 | 7-methylguanosine mRNA capping | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 5 | 24 |
GO:0070534 | protein K63-linked ubiquitination | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 3 | 24 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 7.41e-02 | 1.00e+00 | 3.703 | 1 | 3 | 25 |
GO:0009267 | cellular response to starvation | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 1 | 26 |
GO:0005057 | receptor signaling protein activity | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 2 | 26 |
GO:0010467 | gene expression | 7.91e-02 | 1.00e+00 | 1.283 | 4 | 49 | 535 |
GO:0001701 | in utero embryonic development | 8.07e-02 | 1.00e+00 | 2.080 | 2 | 7 | 154 |
GO:0016881 | acid-amino acid ligase activity | 8.27e-02 | 1.00e+00 | 3.539 | 1 | 3 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 8.55e-02 | 1.00e+00 | 3.489 | 1 | 4 | 29 |
GO:0000737 | DNA catabolic process, endonucleolytic | 8.55e-02 | 1.00e+00 | 3.489 | 1 | 2 | 29 |
GO:0006446 | regulation of translational initiation | 8.55e-02 | 1.00e+00 | 3.489 | 1 | 2 | 29 |
GO:0008380 | RNA splicing | 9.08e-02 | 1.00e+00 | 1.980 | 2 | 21 | 165 |
GO:0051865 | protein autoubiquitination | 9.11e-02 | 1.00e+00 | 3.392 | 1 | 2 | 31 |
GO:0009408 | response to heat | 9.11e-02 | 1.00e+00 | 3.392 | 1 | 1 | 31 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 9.11e-02 | 1.00e+00 | 3.392 | 1 | 6 | 31 |
GO:0045111 | intermediate filament cytoskeleton | 9.11e-02 | 1.00e+00 | 3.392 | 1 | 3 | 31 |
GO:0044267 | cellular protein metabolic process | 9.22e-02 | 1.00e+00 | 1.472 | 3 | 14 | 352 |
GO:0017148 | negative regulation of translation | 9.67e-02 | 1.00e+00 | 3.302 | 1 | 5 | 33 |
GO:0000786 | nucleosome | 9.95e-02 | 1.00e+00 | 3.259 | 1 | 2 | 34 |
GO:0007254 | JNK cascade | 9.95e-02 | 1.00e+00 | 3.259 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 5 | 35 |
GO:0031124 | mRNA 3'-end processing | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 4 | 35 |
GO:0070936 | protein K48-linked ubiquitination | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 1 | 35 |
GO:0044297 | cell body | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 5 | 35 |
GO:0006412 | translation | 1.03e-01 | 1.00e+00 | 1.871 | 2 | 12 | 178 |
GO:0043434 | response to peptide hormone | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 1 | 36 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.11e-01 | 1.00e+00 | 3.099 | 1 | 4 | 38 |
GO:0006369 | termination of RNA polymerase II transcription | 1.11e-01 | 1.00e+00 | 3.099 | 1 | 5 | 38 |
GO:0048511 | rhythmic process | 1.11e-01 | 1.00e+00 | 3.099 | 1 | 5 | 38 |
GO:0016567 | protein ubiquitination | 1.13e-01 | 1.00e+00 | 1.792 | 2 | 14 | 188 |
GO:0006396 | RNA processing | 1.16e-01 | 1.00e+00 | 3.025 | 1 | 4 | 40 |
GO:0003684 | damaged DNA binding | 1.19e-01 | 1.00e+00 | 2.989 | 1 | 1 | 41 |
GO:0000724 | double-strand break repair via homologous recombination | 1.21e-01 | 1.00e+00 | 2.954 | 1 | 5 | 42 |
GO:0005743 | mitochondrial inner membrane | 1.22e-01 | 1.00e+00 | 1.724 | 2 | 9 | 197 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 1.24e-01 | 1.00e+00 | 2.920 | 1 | 2 | 43 |
GO:0006406 | mRNA export from nucleus | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 7 | 44 |
GO:0009749 | response to glucose | 1.30e-01 | 1.00e+00 | 2.855 | 1 | 1 | 45 |
GO:0001570 | vasculogenesis | 1.30e-01 | 1.00e+00 | 2.855 | 1 | 2 | 45 |
GO:0009612 | response to mechanical stimulus | 1.32e-01 | 1.00e+00 | 2.823 | 1 | 2 | 46 |
GO:0000502 | proteasome complex | 1.35e-01 | 1.00e+00 | 2.792 | 1 | 3 | 47 |
GO:0001558 | regulation of cell growth | 1.40e-01 | 1.00e+00 | 2.732 | 1 | 2 | 49 |
GO:0016032 | viral process | 1.42e-01 | 1.00e+00 | 1.190 | 3 | 30 | 428 |
GO:0006310 | DNA recombination | 1.43e-01 | 1.00e+00 | 2.703 | 1 | 8 | 50 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.48e-01 | 1.00e+00 | 2.646 | 1 | 8 | 52 |
GO:0006338 | chromatin remodeling | 1.56e-01 | 1.00e+00 | 2.565 | 1 | 7 | 55 |
GO:0016311 | dephosphorylation | 1.56e-01 | 1.00e+00 | 2.565 | 1 | 3 | 55 |
GO:0005737 | cytoplasm | 1.60e-01 | 1.00e+00 | 0.443 | 11 | 127 | 2633 |
GO:0008584 | male gonad development | 1.61e-01 | 1.00e+00 | 2.514 | 1 | 1 | 57 |
GO:0042826 | histone deacetylase binding | 1.64e-01 | 1.00e+00 | 2.489 | 1 | 5 | 58 |
GO:0000785 | chromatin | 1.66e-01 | 1.00e+00 | 2.464 | 1 | 6 | 59 |
GO:0005829 | cytosol | 1.69e-01 | 1.00e+00 | 0.543 | 8 | 88 | 1787 |
GO:0071013 | catalytic step 2 spliceosome | 1.72e-01 | 1.00e+00 | 2.416 | 1 | 5 | 61 |
GO:0006464 | cellular protein modification process | 1.72e-01 | 1.00e+00 | 2.416 | 1 | 4 | 61 |
GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding | 1.77e-01 | 1.00e+00 | 2.369 | 1 | 2 | 63 |
GO:0030018 | Z disc | 1.79e-01 | 1.00e+00 | 2.347 | 1 | 3 | 64 |
GO:0008270 | zinc ion binding | 1.81e-01 | 1.00e+00 | 0.841 | 4 | 39 | 727 |
GO:0003676 | nucleic acid binding | 1.84e-01 | 1.00e+00 | 2.302 | 1 | 4 | 66 |
GO:0030308 | negative regulation of cell growth | 1.94e-01 | 1.00e+00 | 2.217 | 1 | 3 | 70 |
GO:0051082 | unfolded protein binding | 1.94e-01 | 1.00e+00 | 2.217 | 1 | 5 | 70 |
GO:0001889 | liver development | 1.97e-01 | 1.00e+00 | 2.197 | 1 | 4 | 71 |
GO:0016363 | nuclear matrix | 2.02e-01 | 1.00e+00 | 2.157 | 1 | 10 | 73 |
GO:0051726 | regulation of cell cycle | 2.02e-01 | 1.00e+00 | 2.157 | 1 | 3 | 73 |
GO:0071456 | cellular response to hypoxia | 2.09e-01 | 1.00e+00 | 2.099 | 1 | 2 | 76 |
GO:0042127 | regulation of cell proliferation | 2.19e-01 | 1.00e+00 | 2.025 | 1 | 4 | 80 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.29e-01 | 1.00e+00 | 1.954 | 1 | 5 | 84 |
GO:0000209 | protein polyubiquitination | 2.48e-01 | 1.00e+00 | 1.823 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.48e-01 | 1.00e+00 | 1.823 | 1 | 6 | 92 |
GO:0006260 | DNA replication | 2.52e-01 | 1.00e+00 | 1.792 | 1 | 9 | 94 |
GO:0000086 | G2/M transition of mitotic cell cycle | 2.59e-01 | 1.00e+00 | 1.747 | 1 | 7 | 97 |
GO:0006457 | protein folding | 2.59e-01 | 1.00e+00 | 1.747 | 1 | 5 | 97 |
GO:0005634 | nucleus | 2.72e-01 | 1.00e+00 | 0.267 | 12 | 158 | 3246 |
GO:0034641 | cellular nitrogen compound metabolic process | 2.77e-01 | 1.00e+00 | 1.632 | 1 | 5 | 105 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.82e-01 | 1.00e+00 | 0.933 | 2 | 23 | 341 |
GO:0043547 | positive regulation of GTPase activity | 2.93e-01 | 1.00e+00 | 1.539 | 1 | 2 | 112 |
GO:0042981 | regulation of apoptotic process | 2.93e-01 | 1.00e+00 | 1.539 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 2.95e-01 | 1.00e+00 | 1.526 | 1 | 6 | 113 |
GO:0007165 | signal transduction | 2.95e-01 | 1.00e+00 | 0.660 | 3 | 24 | 618 |
GO:0000287 | magnesium ion binding | 2.99e-01 | 1.00e+00 | 1.501 | 1 | 4 | 115 |
GO:0006974 | cellular response to DNA damage stimulus | 3.12e-01 | 1.00e+00 | 1.428 | 1 | 11 | 121 |
GO:0046872 | metal ion binding | 3.22e-01 | 1.00e+00 | 0.479 | 4 | 24 | 934 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.23e-01 | 1.00e+00 | 0.788 | 2 | 21 | 377 |
GO:0003677 | DNA binding | 3.31e-01 | 1.00e+00 | 0.459 | 4 | 52 | 947 |
GO:0031625 | ubiquitin protein ligase binding | 3.48e-01 | 1.00e+00 | 1.238 | 1 | 7 | 138 |
GO:0005622 | intracellular | 3.62e-01 | 1.00e+00 | 1.167 | 1 | 2 | 145 |
GO:0016874 | ligase activity | 3.64e-01 | 1.00e+00 | 1.157 | 1 | 11 | 146 |
GO:0006355 | regulation of transcription, DNA-templated | 3.78e-01 | 1.00e+00 | 0.450 | 3 | 31 | 715 |
GO:0005874 | microtubule | 3.97e-01 | 1.00e+00 | 0.998 | 1 | 10 | 163 |
GO:0016071 | mRNA metabolic process | 4.10e-01 | 1.00e+00 | 0.937 | 1 | 10 | 170 |
GO:0000166 | nucleotide binding | 4.21e-01 | 1.00e+00 | 0.887 | 1 | 13 | 176 |
GO:0006351 | transcription, DNA-templated | 4.25e-01 | 1.00e+00 | 0.275 | 4 | 47 | 1076 |
GO:0016070 | RNA metabolic process | 4.42e-01 | 1.00e+00 | 0.792 | 1 | 10 | 188 |
GO:0044822 | poly(A) RNA binding | 4.50e-01 | 1.00e+00 | 0.289 | 3 | 45 | 799 |
GO:0035556 | intracellular signal transduction | 4.61e-01 | 1.00e+00 | 0.710 | 1 | 5 | 199 |
GO:0030154 | cell differentiation | 4.70e-01 | 1.00e+00 | 0.674 | 1 | 5 | 204 |
GO:0043234 | protein complex | 4.80e-01 | 1.00e+00 | 0.632 | 1 | 13 | 210 |
GO:0019899 | enzyme binding | 4.80e-01 | 1.00e+00 | 0.632 | 1 | 7 | 210 |
GO:0007275 | multicellular organismal development | 4.86e-01 | 1.00e+00 | 0.605 | 1 | 9 | 214 |
GO:0019901 | protein kinase binding | 5.14e-01 | 1.00e+00 | 0.489 | 1 | 8 | 232 |
GO:0005730 | nucleolus | 5.24e-01 | 1.00e+00 | 0.097 | 4 | 74 | 1217 |
GO:0005524 | ATP binding | 5.25e-01 | 1.00e+00 | 0.131 | 3 | 37 | 892 |
GO:0008283 | cell proliferation | 5.25e-01 | 1.00e+00 | 0.446 | 1 | 8 | 239 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 5.41e-01 | 1.00e+00 | 0.162 | 2 | 22 | 582 |
GO:0006508 | proteolysis | 5.61e-01 | 1.00e+00 | 0.302 | 1 | 11 | 264 |
GO:0046982 | protein heterodimerization activity | 5.62e-01 | 1.00e+00 | 0.297 | 1 | 11 | 265 |
GO:0043565 | sequence-specific DNA binding | 5.76e-01 | 1.00e+00 | 0.243 | 1 | 8 | 275 |
GO:0008285 | negative regulation of cell proliferation | 5.79e-01 | 1.00e+00 | 0.233 | 1 | 11 | 277 |
GO:0008284 | positive regulation of cell proliferation | 5.81e-01 | 1.00e+00 | 0.222 | 1 | 8 | 279 |
GO:0048471 | perinuclear region of cytoplasm | 6.60e-01 | 1.00e+00 | -0.080 | 1 | 11 | 344 |
GO:0005509 | calcium ion binding | 6.67e-01 | 1.00e+00 | -0.109 | 1 | 9 | 351 |
GO:0042802 | identical protein binding | 6.70e-01 | 1.00e+00 | -0.121 | 1 | 15 | 354 |
GO:0005783 | endoplasmic reticulum | 6.98e-01 | 1.00e+00 | -0.227 | 1 | 12 | 381 |
GO:0006915 | apoptotic process | 7.25e-01 | 1.00e+00 | -0.336 | 1 | 15 | 411 |
GO:0042803 | protein homodimerization activity | 7.40e-01 | 1.00e+00 | -0.395 | 1 | 13 | 428 |
GO:0005887 | integral component of plasma membrane | 8.39e-01 | 1.00e+00 | -0.821 | 1 | 8 | 575 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 8.71e-01 | 1.00e+00 | -0.984 | 1 | 29 | 644 |
GO:0016020 | membrane | 9.00e-01 | 1.00e+00 | -0.891 | 2 | 56 | 1207 |
GO:0070062 | extracellular vesicular exosome | 9.01e-01 | 1.00e+00 | -0.749 | 3 | 51 | 1641 |
GO:0044281 | small molecule metabolic process | 9.34e-01 | 1.00e+00 | -1.375 | 1 | 35 | 844 |
GO:0016021 | integral component of membrane | 9.94e-01 | 1.00e+00 | -2.229 | 1 | 19 | 1526 |
GO:0005886 | plasma membrane | 9.98e-01 | 1.00e+00 | -2.454 | 1 | 46 | 1784 |